✦ LIBER ✦

P.408 Safety and efficacy of a 24-week course of pegylated interferon α-2a and ribavirin for the treatment of acute HCV infection in HIV positive patients

✍ Scribed by S.S.D. Dominguez; J.J.G. Ghosn; A. Schruniger; M. Valantin; A. Simon; D. Bollens; P. Campa; P. Bonnard; L. Slama; B. Autran; V. Thibault; C. Katlama

Book ID: 117770617
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 282 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80581-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Pegylated Interfe

Efficacy and Safety of Pegylated Interferon- α 2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Patients

✍ Santin, Miguel; Shaw, Evelyn; Garcia, M. Jose; Delejido, Antonio; De Castro, Edu 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 107 KB

630 Baseline factors associated with hae

630 Baseline factors associated with haematological toxicity of pegylated interferon α-2a and ribavirin for the treatment of HCV infection in HIV coinfected patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Role of Pegylated Interferon-α-2a and Ri

Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

✍ Lopez-Cortes, LF; Valera-Bestard, B; Gutierrez-Valencia, A; Ruiz-Valderas, R; Ji 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 205 KB

[10] THE SAFETY AND EFFICACY OF TARIBAVI

[10] THE SAFETY AND EFFICACY OF TARIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a VERSUS RIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a IN THERAPY-NAIVE PATIENTS INFECTED WITH HCV: PHASE 3 RESULTS

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

547 Mitochondrial effects of a 24-week c

547 Mitochondrial effects of a 24-week course of pegylated-interferon (PEG-IFN) plus ribavirin (RBV) in asymptomatic HCV/HIV CO-infected patients on long-term treatment with didanosine, stavudine or both

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 104 KB

OC-27 An open, randomized, multicentre t

OC-27 An open, randomized, multicentre trial to evaluate efficacy and safety of a 24 week-course of Peg-interferon α-2b versus a 12 week-course of Peg-Interferon α-2b alone or plus ribavirin in patients with acute hepatitis C

✍ Santantonio, T.; Fasano, M.; Sagnelli, E.; Tundo, P.; Babudieri, S.; Fabris, P.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 75 KB